Peer Review History: Identification of Novel Drug Compound for the Mutated Protein (PKBB-Protein Kinase B, Beta) Responsible for Endometrial Cancer Using Advanced Insilico Drug Designing Technique

Editor(s):

(1) Dr. Takashi Ikeno, National Cancer Center Hospital East, Japan.

(2) Dr. Ana Cláudia Correia Coelho, University of Trás-os-Montes and Alto Douro, Portugal.

Reviewers:

(1) Devendra Singh Lodhi, India.

(2) Ayesha Afreen Islam, Institute of Post Graduate Medical Education and Research, Kolkata, India.

(3) Sakineh Hajebrahimi, Tabriz University of Sciences, Iran.

Additional Reviewers:

Additional Reviewers: (Comments received after deadline)

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 8.16/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

Stage 1 | Original Manuscript | File 1 | NA

Stage 2 | Peer Review Report_1 (Devendra Singh Lodhi, India) | File 1 | NA

Stage 2 | Peer Review Report_2 (Ayesha Afreen Islam, India) | File 1 | NA

Stage 2 | Peer Review Report_3 (Sakineh Hajebrahimi, Iran) | File 1 | NA

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

Stage 3 | Comment_Editor_2_v1 | File 1 | NA